Rectal Cancer: Redox State of Venous Blood and Tissues of Blood Vessels from Electron Paramagnetic Resonance and Its Correlation with the Five-Year Survival by unknown
BioMed Research International 2018 vol.2018
Rectal Cancer: Redox State of Venous Blood and Tissues
of Blood Vessels from Electron Paramagnetic Resonance
and Its Correlation with the Five-Year Survival
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© 2018 A. P. Burlaka et al. A role of pro- and antioxidants for reducing rectal cancer (RC)
incidence  in  operative,  preoperative,  and  postoperative  treatments  is  still  disputable  and
controversial. The redox state of venous blood and tissues of blood vessels of 60 patients with
RC (T2-4N0-2M0G2) and 20 donors is studied by means of the conventional and spin-trapping
electron paramagnetic resonance (EPR). The intensity of the signals from ceruloplasmin (CP),
transferrin (TF),  and labile iron pool  (LIP)  at  temperature T = 77 K as well  as superoxide
generation rate and nitric oxide (NO) levels at T = 300 K is measured. The reduced CP and TF
activity and decreased NO levels  increased LIP levels  and superoxide-generating rates are
detected in blood species. Correlation analysis for the five-year survival rate as a function of the
extracted values is done. The results show that the intensities of the corresponding EPR signals
from  the  "native"  and  "trapped"  paramagnetic  centers  can  be  potentially  used  for  the
understanding of the molecular mechanisms underlying the RC progression and treatment.
http://dx.doi.org/10.1155/2018/4848652
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